The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...
A new study published in the European Journal of Heart Failure reveals that the speed of lymph flow in the legs may determine ...
SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination ...
Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and ...
FDA has approved the new furosemide injection for treating edema in adults with chronic heart failure.Lasix ONYU was ...
ANSWER: It is common to retain fluid after a salty meal. This can often be noticed due to tight rings on your fingers, socks ...
Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.
Dear B.H.: It is common to retain fluid after a salty meal. This can often be noticed due to tight rings on your fingers, ...
US FDA approves Corstasis Therapeutics’ Enbumyst to treat edema associated with congestive heart failure, liver disease and kidney disease: Henderson, Nevada Saturday, September ...
The total number of outstanding shares of the Company mentioned in the relevant transparency notification amounts to 63,145,080, each share giving right to one (1) vote (being 63,145,080 voting rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback